Lee, M. K. http://orcid.org/0000-0002-1301-4319
Basch, E.
Mitchell, S. A.
Minasian, L. M.
Langlais, B. T.
Thanarajasingam, G.
Ginos, B. F.
Rogak, L. J.
Mendoza, T. R.
Bennett, A. V.
Schrag, D.
Mazza, G. L.
Dueck, A. C.
Funding for this research was provided by:
National Cancer Institute (U01 CA233046, HHSN261200800043C)
Article History
Accepted: 10 February 2023
First Online: 10 March 2023
Declarations
:
: EB reports research funding to the University of North Carolina from the National Cancer Institute and Patient-Centered Outcomes Research Institute, and direct funding as a scientific advisor to Sivan, Carevive, Resilience, N-Power, Navigating Cancer, and AstraZeneca. DS reports research funding to the Dana Farber Cancer Institute from the National Cancer Institute, Patient-Centered Outcomes Research Institute, and American Association of Cancer Research, and Grail. She reports serving as an uncompensated advisor to Grail and as a compensated advisor to the Centers for Medicare and Medicaid Services, and to several states and International Governments. She reports compensation from JAMA for editorial services. <i>Other authors</i> declare they have no competing interests.